Secondary Attack Rate of Hepatitis C Virus (HCV)
The transmission routes of Hepatitis C Virus (HCV) are categorized as horizontal and vertical. The former includes sexual contact, parenteral exposure, and intrafamilial transmission, while the latter pertains to mother-to-child transmission. Although extensive literature has documented the parenter...
Saved in:
| Published in: | Annals of hepatology Vol. 29; p. 101392 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier España, S.L.U
01-02-2024
Elsevier |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The transmission routes of Hepatitis C Virus (HCV) are categorized as horizontal and vertical. The former includes sexual contact, parenteral exposure, and intrafamilial transmission, while the latter pertains to mother-to-child transmission. Although extensive literature has documented the parenteral route and sexual contact, there is a paucity of studies examining intrafamilial transmission within the Mexican population. This study aims to determine the rate of horizontal viral transmission among first-degree relatives of patients diagnosed with HCV infection who received treatment at Hospital de Especialidades No. 14, Centro Medico Nacional "Adolfo Ruiz Cortines."
The study design is observational, descriptive, and retrospective. Patient records from outpatient clinics were scrutinized for the period spanning January 2018 to January 2022. Clinical and epidemiological characteristics, risk factors obtained from medical histories, and laboratory results (including positive HCV viral load and HCV serum PCR test) were evaluated to classify cohorts. Informed consent was obtained from all patients. The research work was registered and approved by the Local Research Committee (R-2022-3001-088).
A total of 129 patients were analyzed, with an average age of 39.56 years. Female gender predominated among 68 patients (52.7%), and 29 patients (22.5%) acquired HCV infection. The primary risk factors identified were Systemic Arterial Hypertension (RR: 7.47, 95% CI: 2.951-18.914, p<0.05), Type 2 Diabetes Mellitus (RR: 16.125, 95% CI: 5.985-43.441, p<0.05), and Chronic Kidney Disease (RR: 10.795, 95% CI: 3.736-31.188, p<0.05) (Table 1). Only two patients (6.89%) were classified as having chronic infection based on measured viral load. All patients received Direct-Acting Antiviral treatment, resulting in sustained viral response at three months post-treatment completion. The primary attack rate was 22.48%, the secondary attack rate was 412.5%, and the R0 was 1,492,953 (Table 2).
The study demonstrated that first-degree relatives with comorbidities are at a higher risk of contracting HCV infection. The study's findings also revealed that the prevalence of HCV infection is higher than the reported rate in the general population. These results highlight the importance of targeted screening programs, especially in high-risk populations with comorbidities, to identify and treat HCV infections promptly. Such efforts will contribute significantly to the international goals for eradicating this virus and preventing further transmission. Moreover, the study's findings underscore the need for increased awareness and preventive measures to reduce the impact of HCV within the Mexican population. |
|---|---|
| ISSN: | 1665-2681 2659-5982 |
| DOI: | 10.1016/j.aohep.2024.101392 |